Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Executive Vice President | December 23, 2010 | December 30, 2010 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date December 23, 2010 · Filed December 30, 2010
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 168,071 |
Reported balance
After 2010-12-23 transaction · row 1
1 source rowRow 1 · 2010-12-23 · Gift · Disposed 1,054 · Balance 168,071 |
| Common shares without par valueSEC Table I · non-derivative | IndirectProfit Sharing Trust | 15,152 |
Reported balance
Holding disclosure · report date 2010-12-23 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 15,152 F1: Balance in the Abbott Laboratories Stock Retirement Trust as of December 28, 2010. |
| Common shares without par valueSEC Table I · non-derivative | IndirectBy wife for daughter | 295 |
Reported balance
Holding disclosure · report date 2010-12-23 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 295 F2: The reporting person disclaims beneficial ownership of all securities held by his daughters. |
| Common shares without par valueSEC Table I · non-derivative | IndirectBy wife for daughter | 296 |
Reported balance
Holding disclosure · report date 2010-12-23 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 296 F2: The reporting person disclaims beneficial ownership of all securities held by his daughters. |
Filing footnotes · ownership attribution and instrument terms
F1: Balance in the Abbott Laboratories Stock Retirement Trust as of December 28, 2010.
F2: The reporting person disclaims beneficial ownership of all securities held by his daughters.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 23, 2010 Filed Dec 30, 2010 22:05 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 1,054 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-10-018248 · edgar.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,071 Read SEC document |
| November 10, 2010 Filed Nov 12, 2010 22:08 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 150 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-10-015977 · edgar.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,125 Read SEC document |
| February 26, 2010 Filed Mar 2, 2010 23:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 400 | $54.31 | $21,724.40 |
DisclosureSEC source: 0001179110-10-004229 · edgar.xml · nonDerivative · entry 13 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,275 Read SEC document |
| February 26, 2010 Filed Mar 2, 2010 23:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 4,803 | $54.31 | $260,850.93 |
DisclosureSEC source: 0001179110-10-004229 · edgar.xml · nonDerivative · entry 12 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,675 Read SEC document |
| February 26, 2010 Filed Mar 2, 2010 23:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 500 | $54.31 | $27,155.35 |
DisclosureSEC source: 0001179110-10-004229 · edgar.xml · nonDerivative · entry 11 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,478 Read SEC document |
| February 26, 2010 Filed Mar 2, 2010 23:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 4,995 | $54.33 | $271,378.35 |
DisclosureSEC source: 0001179110-10-004229 · edgar.xml · nonDerivative · entry 10 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,978 Read SEC document |
| February 26, 2010 Filed Mar 2, 2010 23:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 800 | $54.32 | $43,456.00 |
DisclosureSEC source: 0001179110-10-004229 · edgar.xml · nonDerivative · entry 9 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,973 Read SEC document |
| February 26, 2010 Filed Mar 2, 2010 23:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $54.33 | $10,866.06 |
DisclosureSEC source: 0001179110-10-004229 · edgar.xml · nonDerivative · entry 8 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,773 Read SEC document |
| February 26, 2010 Filed Mar 2, 2010 23:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 500 | $54.33 | $27,165.10 |
DisclosureSEC source: 0001179110-10-004229 · edgar.xml · nonDerivative · entry 7 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,973 Read SEC document |
| February 26, 2010 Filed Mar 2, 2010 23:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,000 | $54.33 | $54,333.00 |
DisclosureSEC source: 0001179110-10-004229 · edgar.xml · nonDerivative · entry 6 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,473 Read SEC document |
| February 26, 2010 Filed Mar 2, 2010 23:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 3,000 | $54.33 | $162,993.00 |
DisclosureSEC source: 0001179110-10-004229 · edgar.xml · nonDerivative · entry 5 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,473 Read SEC document |
| February 26, 2010 Filed Mar 2, 2010 23:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $54.33 | $5,433.05 |
DisclosureSEC source: 0001179110-10-004229 · edgar.xml · nonDerivative · entry 4 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,473 Read SEC document |
| February 26, 2010 Filed Mar 2, 2010 23:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $54.33 | $10,866.08 |
DisclosureSEC source: 0001179110-10-004229 · edgar.xml · nonDerivative · entry 3 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,573 Read SEC document |
| February 26, 2010 Filed Mar 2, 2010 23:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,100 | $54.33 | $59,763.66 |
DisclosureSEC source: 0001179110-10-004229 · edgar.xml · nonDerivative · entry 2 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,773 Read SEC document |
| February 26, 2010 Filed Mar 2, 2010 23:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 11,469 | $54.12 | $620,702.28 |
DisclosureSEC source: 0001179110-10-004229 · edgar.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,873 Read SEC document |
| February 19, 2010 Filed Feb 24, 2010 01:47 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 46,900 | $0.00 Strike: $54.50 | $0.00 |
DisclosureSEC source: 0001179110-10-003591 · edgar.xml · derivative · entry 6 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,900 Underlying: Common shares · 46,900 shares Expires 2020-02-18 F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 15,634 on 2/19/2011, 15,633 on 2/19/2012, and 15,633 on 2/19/2013. Read SEC document |
| February 19, 2010 Filed Feb 24, 2010 01:47 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 32,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-10-003591 · edgar.xml · nonDerivative · entry 2 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,342 F2 · shares: These shares represent a retention award of restricted stock under the Abbott Laboratories 2009 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes. Read SEC document |
| February 19, 2010 Filed Feb 24, 2010 01:47 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 32,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-10-003591 · edgar.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,342 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 16, 2010 Filed Feb 18, 2010 23:35 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $54.49 | $5,449.13 |
DisclosureSEC source: 0001179110-10-003167 · edgar.xml · nonDerivative · entry 8 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,342 Read SEC document |
| February 16, 2010 Filed Feb 18, 2010 23:35 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $54.49 | $5,449.12 |
DisclosureSEC source: 0001179110-10-003167 · edgar.xml · nonDerivative · entry 7 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,442 Read SEC document |
| February 16, 2010 Filed Feb 18, 2010 23:35 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $54.49 | $5,449.10 |
DisclosureSEC source: 0001179110-10-003167 · edgar.xml · nonDerivative · entry 6 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,542 Read SEC document |
| February 16, 2010 Filed Feb 18, 2010 23:35 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 8,540 | $54.49 | $465,344.60 |
DisclosureSEC source: 0001179110-10-003167 · edgar.xml · nonDerivative · entry 5 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,642 Read SEC document |
| February 16, 2010 Filed Feb 18, 2010 23:35 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,700 | $54.51 | $92,667.00 |
DisclosureSEC source: 0001179110-10-003167 · edgar.xml · nonDerivative · entry 4 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,182 Read SEC document |
| February 16, 2010 Filed Feb 18, 2010 23:35 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,800 | $54.50 | $152,600.00 |
DisclosureSEC source: 0001179110-10-003167 · edgar.xml · nonDerivative · entry 3 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,882 Read SEC document |
| February 16, 2010 Filed Feb 18, 2010 23:35 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,200 | $54.51 | $65,413.20 |
DisclosureSEC source: 0001179110-10-003167 · edgar.xml · nonDerivative · entry 2 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,682 Read SEC document |
| February 16, 2010 Filed Feb 18, 2010 23:35 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 6,460 | $53.93 | $348,387.80 |
DisclosureSEC source: 0001179110-10-003167 · edgar.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,882 Read SEC document |
| December 29, 2009 Filed Dec 30, 2009 22:17 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 7,530 | $0.00 Strike: $53.40 | $0.00 |
DisclosureSEC source: 0001179110-09-017578 · edgar.xml · derivative · entry 7 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 7,530 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| December 29, 2009 Filed Dec 30, 2009 22:17 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 30 | $54.76 | $1,642.80 |
DisclosureSEC source: 0001179110-09-017578 · edgar.xml · nonDerivative · entry 3 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,342 Read SEC document |
| December 29, 2009 Filed Dec 30, 2009 22:17 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 7,500 | $54.75 | $410,625.00 |
DisclosureSEC source: 0001179110-09-017578 · edgar.xml · nonDerivative · entry 2 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,372 Read SEC document |
| December 29, 2009 Filed Dec 30, 2009 22:17 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 7,530 | $53.40 | $402,102.00 |
DisclosureSEC source: 0001179110-09-017578 · edgar.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,872 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 10, 2009 Filed Dec 11, 2009 23:51 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 3,865 | $0.00 Strike: $52.25 | $0.00 |
DisclosureSEC source: 0001179110-09-016824 · edgar.xml · derivative · entry 7 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 3,865 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| December 10, 2009 Filed Dec 11, 2009 23:51 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 65 | $54.26 | $3,526.90 |
DisclosureSEC source: 0001179110-09-016824 · edgar.xml · nonDerivative · entry 3 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,342 Read SEC document |
| December 10, 2009 Filed Dec 11, 2009 23:51 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon Shares without par value | 3,800 | $54.25 | $206,150.00 |
DisclosureSEC source: 0001179110-09-016824 · edgar.xml · nonDerivative · entry 2 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,407 Read SEC document |
| December 10, 2009 Filed Dec 11, 2009 23:51 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 3,865 | $52.25 | $201,957.46 |
DisclosureSEC source: 0001179110-09-016824 · edgar.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,207 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 10, 2009 Filed Dec 31, 2009 22:05 UTC Amendment | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 3,865 | $0.00 Strike: $52.25 | $0.00 |
DisclosureSEC source: 0001179110-09-017638 · edgar.xml · derivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 3,865 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. F2 · shares: The Form 4 filed on December 11, 2009 inadvertently reported that the exercised options were acquired, rather than disposed of, by the reporting person. Read SEC document |
| December 07, 2009 Filed Dec 9, 2009 22:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 100 | $0.00 Strike: $52.25 | $0.00 |
DisclosureSEC source: 0001179110-09-016642 · edgar.xml · derivative · entry 6 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,865 Underlying: Common Shares · 100 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| December 07, 2009 Filed Dec 9, 2009 22:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $54.25 | $5,425.00 |
DisclosureSEC source: 0001179110-09-016642 · edgar.xml · nonDerivative · entry 2 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,342 Read SEC document |
| December 07, 2009 Filed Dec 9, 2009 22:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 100 | $52.25 | $5,225.29 |
DisclosureSEC source: 0001179110-09-016642 · edgar.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,442 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 07, 2009 Filed Dec 31, 2009 22:05 UTC Amendment | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 100 | $0.00 Strike: $52.25 | $0.00 |
DisclosureSEC source: 0001179110-09-017637 · edgar.xml · derivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,865 Underlying: Common Shares · 100 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. F2 · shares: The Form 4 filed on December 9, 2009 inadvertently reported that the exercised options were acquired, rather than disposed of, by the reporting person. Read SEC document |
| February 27, 2009 Filed Mar 4, 2009 00:17 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $47.85 | $4,785.00 |
DisclosureSEC source: 0001104659-09-013945 · a4.xml · nonDerivative · entry 3 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,342 Read SEC document |
| February 27, 2009 Filed Mar 4, 2009 00:17 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 10,334 | $47.84 | $494,378.56 |
DisclosureSEC source: 0001104659-09-013945 · a4.xml · nonDerivative · entry 2 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,442 Read SEC document |
| February 27, 2009 Filed Mar 4, 2009 00:17 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 6,800 | $50.58 | $343,944.00 |
DisclosureSEC source: 0001104659-09-013945 · a4.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,776 Read SEC document |
| February 20, 2009 Filed Feb 24, 2009 22:05 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 50,400 | $0.00 Strike: $54.14 | $0.00 |
DisclosureSEC source: 0001104659-09-011819 · a4.xml · derivative · entry 5 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,400 Underlying: Common shares · 50,400 shares Expires 2019-02-19 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 16,800 on 2/20/2010, 16,800 on 2/20/2011 and 16,800 on 2/20/2012. Read SEC document |
| February 20, 2009 Filed Feb 24, 2009 22:05 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 35,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-09-011819 · a4.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,576 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The awards have a 5 year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 17, 2009 Filed Feb 20, 2009 01:54 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 700 | $54.14 | $37,898.70 |
DisclosureSEC source: 0001104659-09-010840 · a4.xml · nonDerivative · entry 3 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,076 Read SEC document |
| February 17, 2009 Filed Feb 20, 2009 01:54 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 5,531 | $54.13 | $299,404.09 |
DisclosureSEC source: 0001104659-09-010840 · a4.xml · nonDerivative · entry 2 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,776 Read SEC document |
| February 17, 2009 Filed Feb 20, 2009 01:54 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 2,602 | $54.94 | $142,953.88 |
DisclosureSEC source: 0001104659-09-010840 · a4.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,307 Read SEC document |
| February 04, 2009 Filed Feb 6, 2009 23:43 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 894 | $0.00 Strike: $56.98 | $0.00 |
DisclosureSEC source: 0001104659-09-007393 · a4.xml · derivative · entry 7 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 894 Underlying: Common shares · 894 shares Expires 2011-02-08 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 04, 2009 Filed Feb 6, 2009 23:43 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 1,028 | $0.00 Strike: $45.45 | $0.00 |
DisclosureSEC source: 0001104659-09-007393 · a4.xml · derivative · entry 6 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 1,028 shares Expires 2011-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 04, 2009 Filed Feb 6, 2009 23:43 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 894 | $56.98 | $50,940.12 |
DisclosureSEC source: 0001104659-09-007393 · a4.xml · nonDerivative · entry 2 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,909 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.